+34 679 490 537info@nanbiosis.com

Nanbiosis

U13. Tissue & Scaffold Characterization Unit

Ciber bbn

U13. Tissue & Scaffold Characterization Unit

  • Scientific Director: Prof. Miguel Angel Martínez miguelam@unizar.es
  • Scientific Coordinator: Fany Peña fany@uniza.es
  • Entities: Universidad de Zaragoza. Departamento de Ingeniería Mecánica.
  • Address: Campus Río Ebro. Edificio I D I. C/ María de Luna, S/N, 50018 Zaragoza, Spain
  • Phone: 34 976 761 000 ext 5233 / 34 976 761 912
  • Web: I3A-UZ
Nanabiosis-logo Universidad de Zarargoza-U9-U13-U27.
Order request

Description

This platform is coordinated by Dr. E. Peña member of the Applied Mechanics and Bioengineering Group of the Aragón Institute of Engineering Research (I3A) at the University of Zaragoza. The objective of this unit is to provide services for structural and physical characterization of biological tissues and tissue scaffolding, including microstructure, histology and mechanical tests among others. This platform, unique in Spain as regarding its capability, has a clear and direct translational impact, especially in regenerative medicine, implant design and evaluation, as well as in the study of the mechanical behavior of living tissues (especially in the musculoskeletal and cardiovascular systems). Its relationship with the Instituto Aragonés de Ciencias de la Salud (Health Sciences Institute of Aragon), and through it with the Tissue and Blood Bank of Aragon and with the School of Veterinary Science at the Universidad de Zaragoza, allows an easy provision of tissues both from animals (mice, rabbit, sheep, pig) and humans, following in their handling the recommendations of the different ethics committees.

It has several types of INSTRON testing machines specializedin biological tissues, for the characterizationof soft tissues and fibers, as well as an X-ray microCT which allows quantitatively characterizing the microstructure of in vitro samples of hard tissues and of biomaterials for scaffolds. It also has the entire system necessary for performing high-quality histologies which would complete the structural characterization of the previously cited types of tissues (staining of preparations, immunohistochemistry in paraffin with EnVision, laser microdissection, etc.). As additional tests, equipment for determining the permeability of biological tissues and scaffolds under culture conditions, monitoring their variation over time is also available. Finally, the platform is also composed of different types of bioreactors, including perfusion or direct compression on seeded scaffolds for stimulating cell cultures for tissue engineering applications.

News U13

17 Jul

NANBIOSIS researcher Iñaki Ochoa, interviewed in the Heraldo de Aragón criticizes the administrative obstacles to science imposed by law.

Scientists of NANBIOSIS in the University of Zaragoza participated in the assembly held las week that put on the table the risks of applying rules in an incoherent way and without taking into account the reality of the work that researchers develop. The Spanish public contrat law prevents the University to spend more than 15,000 euros per provider per year, which complicates the purchases of material. The scientists ask that this legislation not be applied More than three hundred researchers  have signed a manifesto in which they denounce that some provisions of the new Spanish law on public contracts prevent them[...]

13 Jul

Manuel Doblaré, Unit 13 of NANBIOSIS, SEMNI Award O. C. Zienkiewicz

The Spanish Society of Numerical Methods in Engineering (SEMNI) has awarded the SEMNI O. C. Zienkiewicz prize to Professor Dr. Manuel Doblaré. The SEMNI O. C. Zienkiewicz Award is the highest award given by this company and recognizes, in this case, both the undisputed scientific curriculum of prof. Doblaré as his permanent contribution to the good functioning of this society, of which he has been a founding member and member of its executive committee until 2007, having also organized the Congress of Numerical Methods in Zaragoza in 1996. The prize will be given during the Congress of Numerical Methods to[...]

09 Jun

SINO-SPAIN Biomedical and Pharmaceutical Conference with NANBIOSIS participation

Last 7 June 2018 took place in Zaragoza, the Sino-Spain Biomedical and Pharmaceutical Conference, as a result of years of cooperation with Chinese institutions, organizad by Zaragoza University  and Aragonese Foundation for Research & Development of Aragon Government (ARAID), to promote initiatives and foster bilateral collaboration in biomedical and pharmaceutical sectors between Spain and China. The themes of the forum were: Molecular engineering for biomedical products Diagnoses &Design for new devices for medical uses Tissue Engineering and regenerative medicine Pharmacology and nanometerials for medical application Advanced therapies for cancer research   Researcher of three units of NANBIOSIS partcipated in the Conference: from U13. Tissue &am[...]

29 May

NANBIOSIS participation at VII Conference of Young Researchers of I3A

The I3A organizes the VII Conference of Young Researchers to be held on June 2, 2018. As in past editions, the Confernce will be addressed to all those who are doing the doctoral thesis whose director or co-director is a member of I3A. Scientists of  NANBIOSIS Unit 13 Tissue & Scaffold Characterization Unit will participate with the following poster: Personalized simulation of intraestromal ring insertion surgery (ICRS). Validation with clinical data. Julio Flecha, Miguel Ángel Ariza-Gracia, Jesús Zurita, Begoña Calvo Simulation of cell populations in Organ-On-Chip devices: of the models classics to data driven simulations. Jacobo Ayensa-Jiménez, Marina Pérez Aliacar, Teodora Randelovic, Sara Oliván, Iñaki Ochoa,[...]

04 May

Microfluidic technologies to study the cardiomyopathy processes of Duchenne’s disease

Ignacio Ochoa and Luis Fernandez, researchers of the AMB group of CIBER-BBN and I3A-University of Zaragoza, coordinator of NANBIOSIS U13. Tissue & Scaffold Characterization Unit, are working on the european project “CISTEM – HEART ON CHIP BASED ON INDUCED PLURIPOTENT STEM CELL TECHNOLOGY FOR PERSONALIZED MEDICINE” . They are developing heart on a chip microfluidic devices to study the cardiomyopathy process in the Duchenne muscular distrophy using microfluidic technologies. CISTEM Kick-off Meeting was successfully held on 24th of January 2018 at Elvesys, Paris, France. Representative of the consortium organizations including academic institutions and industry representatives were participating in this meeting: BioSense Institute, Elvesys,[...]

07 Mar

Numerical models applied to the cornea to improve eye surgery

Researchers of the NANBIOSIS U13 apply numerical models to the cornea to better understand how it behaves and help in surgical planning. Data and algorithms developed through the computer, together with the 3D image, make it easier for ophthalmologists to perform eye surgery more precise and personalized treatments for each patient The work carried out by Miguel Ángel Ariza Gracia at the Aragón Engineering Research Institute (I3A) has been recognized by the University of Zaragoza with the Extraordinary Award for the Best Doctoral Thesis of the Biomedical Engineering Program in 2017 In this line of research, framed in the European[...]

23 Feb

NANBIOSIS ICTS invites groups and companies to discuss Smart Biomaterials and devices for Drug Delivery

On February 22nd, the National School of Health of the Carlos III Health Institute hosted the forum on Smart Biomaterials and biomedical devices for applications in drug delivery and regenerative medicine, organized by the ICTS Nanbiosis, an infrastructure shared by the CIBER-BBN and the Center of Minimally Invasive Surgery Jesus Usón (CCMIJU). This is the first groups/companies meeting organized by Nanbiosis, in which about 70 B2B meetings  were held. The meeting brought together about 40 participants from 14 research groups (from the CIBER-BBN and the CCMIJU) and 10 companies, which discussed the latest advances in the research lines developed by the groups[...]

17 Nov

Unit 13 of NANBIOSIS participates in a new European project that will boost the Organ-on-Chip technology

The research group coordinating NANBIOSIS Unit 13 is the Spanish group of the European project ORCHID (Organ-On-Chip In Development). The scientists  of Engineering Research Institute (I3A) and CIBER-BBN, Luis Fernández and Iñaki Ochoa, will work on this project whose objective is to accelerate the social and economic impact of the technology known as Organ-on-Chip. This technology based on the use of microfluidic platforms is already facilitating the discovery of drugs, but it can go a step further with applications in personalized medicine and safety pharmacology and that, in addition, offers alternatives to conventional tests in animals. The mechanical properties and[...]

U13-Tissue & Scaffold Characterization Unit
Read More